Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:GHDX

Genomic Health (GHDX) Stock Price, News & Analysis

Genomic Health logo

About Genomic Health Stock (NASDAQ:GHDX)

Advanced Chart

Key Stats

Today's Range
$63.44
$63.44
50-Day Range
$63.44
$69.79
52-Week Range
$50.77
$90.18
Volume
N/A
Average Volume
1.05 million shs
Market Capitalization
$2.38 billion
P/E Ratio
60.42
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive GHDX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Genomic Health and its competitors with MarketBeat's FREE daily newsletter.

GHDX Stock News Headlines

Trump Did What!?
Last May, President Trump signed four executive orders that could spark the biggest energy disruption in decades. This move opens the door for a next-gen power source with the potential to upend oil and gas, slash emissions, and accelerate artificial intelligence breakthroughs. While stocks tied to this trend have already soared, one overlooked corner of the industry could deliver even bigger gains—and it’s still flying under the radar.
PanGenomic Health Announces CFO Transition
See More Headlines

GHDX Stock Analysis - Frequently Asked Questions

Genomic Health, Inc. (NASDAQ:GHDX) released its quarterly earnings results on Monday, November, 11th. The medical research company reported $0.48 EPS for the quarter, topping the consensus estimate of $0.37 by $0.11. Genomic Health had a trailing twelve-month return on equity of 19.62% and a net margin of 12.81%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Genomic Health investors own include Revance Therapeutics (RVNC), Horizon Therapeutics Public (HZNP), Illumina (ILMN), NVIDIA (NVDA), Ionis Pharmaceuticals (IONS), Vertex Pharmaceuticals (VRTX) and Exelixis (EXEL).

Company Calendar

Last Earnings
11/11/2019
Today
8/03/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Medical Laboratories
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:GHDX
CIK
1131324
Fax
N/A
Employees
829
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
$1.05
Trailing P/E Ratio
60.42
Forward P/E Ratio
40.15
P/E Growth
N/A
Net Income
$25.68 million
Net Margins
12.81%
Pretax Margin
N/A
Return on Equity
19.62%
Return on Assets
14.89%

Debt

Debt-to-Equity Ratio
0.15
Current Ratio
5.96
Quick Ratio
5.96

Sales & Book Value

Annual Sales
$394.11 million
Price / Sales
6.05
Cash Flow
$1.45 per share
Price / Cash Flow
43.76
Book Value
$7.48 per share
Price / Book
8.48

Miscellaneous

Outstanding Shares
37,590,000
Free Float
N/A
Market Cap
$2.38 billion
Optionable
Optionable
Beta
0.90
Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NASDAQ:GHDX) was last updated on 8/4/2025 by MarketBeat.com Staff
From Our Partners